X4 Pharmaceuticals, Inc. (XFOR) Total liabilities 2018–2025
X4 Pharmaceuticals, Inc. (XFOR) total liabilities at each fiscal year-end, per SEC filings.
$104.2MFY2025 · since FY2018: $21.6M → $104.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104.2M | -16.2% |
| FY2024 | $124.3M | +29.3% |
| FY2023 | $96.2M | +17.9% |
| FY2022 | $81.5M | +54.5% |
| FY2021 | $52.8M | +5.4% |
| FY2020 | $50.1M | +59.1% |
| FY2019 | $31.5M | +45.6% |
| FY2018 | $21.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice